Third Dose of COVID-19 Vaccines May Boost Immunity in Patients with Hematologic Cancers - Contagionlive.com

A third dose of mRNA COVID-19 vaccines may allow most immune compromised patients with hematologic cancers to achieve antibody response levels similar to those of healthy adults after a two-dose series.

Immunocompromized patients with hematologic cancers have experienced lower COVID-19 vaccine effectiveness. But a third dose of mRNA vaccine may significantly boost their antibody concentrations, a re… [+3709 chars]

full article...